Yahoo Web Search

Search results

  1. Dec 16, 2020 · Chinese health care giant Fosun Pharma has secured a deal with BioNTech to buy 100 million doses of their coronavirus vaccine for use and distribution in mainland China. The deal will be...

  2. Dec 22, 2022 · Approximately 11,500 of the companies’ mRNA-based COVID-19 vaccine doses arrived on the Chinese Mainland to enable vaccination campaign for German expatriates. Vaccines expected to be...

  3. Jul 15, 2021 · SHANGHAI, July 15 (Reuters) - Chinese regulators have completed an expert review of a COVID-19 mRNA vaccine developed by Germany's BioNTech (22UAy.DE) and Fosun Pharma (600196.SS) and the...

  4. Jan 9, 2021 · Early in the pandemic, on March 15, Fosun Pharma agreed to invest $135 million in BioNTech to conduct clinical trials and buy the rights to exclusively license BioNTech’s COVID-19 vaccine...

    • grady.mcgregor@fortune.com
  5. Nov 28, 2022 · The bivalent vaccine contains 15-µg of mRNA encoding for the spike-protein of the wild-type of SARS-CoV-2, which is present in the original mRNA COVID-19 vaccine, and 15-µg of mRNA encoding for...

  6. Dec 16, 2020 · BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine. 16 December 2020. PDF Version. Supply agreement reflects both companies’ shared commitment and efforts to achieve vaccine accessibility and affordability in China. A local Phase 2 clinical trial of mRNA COVID-19 vaccine candidate BNT162b2 is on-going in Jiangsu, China.

  7. Dec 14, 2021 · With the release of its BioNTech vaccine plagued by regulatory delays, Fosun Pharma has this year ramped up investments into Chinese biotech firms, including Kintor Pharmaceutical, a Chinese...

  1. People also search for